It appears that your browser has cookies disabled.
The website requires your browser to enable cookies in order to login.
Please enable cookies and reload this page.
Advancing Cancer Diagnostics, Improving Lives
Select Your Country/Region
Your location doesnt match the address (URL), do you want to change it?
Each country/region may have its own set of regulatory requirements and medical practices. The information found on each country version of our website is specific to and applicable for only that country/region. This includes (but is not limited to) all product details/availability, documentation, pricing, and promotions.
MYC (8q24) / SE 8 hybridized to a metaphase spread showing a normal pattern.
MYC (8q24) / SE 8 hybridized to a metaphase spread showing a normal pattern.
IVD MYC/SE 8
The MYC (previously known as C-MYC) gene produces an oncogenic transcription factor that affects diverse cellular processes involved in cell growth, cell proliferation, apoptosis and cellular metabolism. The MYC oncogene has been shown to be amplified in many types of human cancer such as bladder, breast and cervical. Amplification at 8q24 including MYC is also observed in 5% of CLL patients. MYC is also the prototype for oncogene activation by chromosomal translocation. The MYC (8q24) specific FISH probe is optimized to detect copy numbers of the MYC gene region at 8q24. The chromosome 8 Satellite Enumeration FISH probe (SE 8) at D8Z1 is included to facilitate chromosome identification.
References: Greil et al, 1991, Blood, 78; 180-191.